0000-0001-6527-3833 Employment
-
Cadila Healthcare (India) Senior Scientist/Team Lead2010 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (13)
- Safety, Tolerability and Pharmacokinetics of a Novel Triaminopyrimidine ZY-19489: A Randomised Double-blind Placebo-control Phase-1 Study among Healthy Indian Participants Save
- An insight into the presence of impurities in reference standards and their impact on mass spectrometry-based bioanalysis Save
- Simultaneous Estimation of Zy-19489 and Its Active Metabolitezy-20486 in Human Plasma Using Lc–Ms/Ms, a Novel Antimalarial Compound Save
- Estimation of ZYKR1 in human urine and plasma utilizing LC-MS/MS positive electrospray ionization; a kappa opioid receptor (KOR) agonist Save
- One Should avoid retro-orbital pharmacokinetic sample collections for Intranasal Dosing in rats: Illustration of spurious pharmacokinetics generated for anti-migraine drugs Zolmitriptan and Eletriptan Save
- Comparative pharmacokinetics of Cholecalciferol in Dogs from two different oral formulations using corrective measures to overcome interference from endogenous cholecalciferol Save
- A sensitive quantitative assay for the determination of Propafenone and two metabolites, 5-Hydroxypropafenone and N-Depropylpropafenone, in Human K2EDTA Plasma Using LC-MS/MS with ESI operated in a positive mode Save
- Is the Inhibition of Dipeptidyl Peptidase-4 (DPP-4) enzyme route dependent and/or driven by high peak concentration? Seeking answers with ZYDPLA1, a novel long acting DPP-4 Inhibitor, in a rodent model Save
- Review of the Bioanalytical Methods for the Determination of Methotrexate and its Metabolites in In-Vitro, Pre-Clinical and Clinical Studies: Case Studies and Perspectives Save
- Quantitative determination of Saroglitazar, a predominantly PPAR alpha agonist, in human plasma by a LC-MS/MS Method Utilizing Electrospray Ionization in a positive mode Save